Bystroff C, Baker D, Fletterick R J, Agard D A
Howard Hughes Medical Institute and the Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448, USA.
Acta Crystallogr D Biol Crystallogr. 1993 Sep 1;49(Pt 5):440-8. doi: 10.1107/S0907444993004020.
The previous paper described a phase-refinement strategy for protein crystallography which exploited the information that proteins consist of connected linear chains of atoms. Here the method is applied to a molecular-replacement problem, the structure of the protease inhibitor ecotin bound to trypsin, and a single isomorphous replacement problem, the structure of the N-terminal domain of apolipoprotein E. The starting phases for the ecotin-trypsin complex were based on a partial model (trypsin) containing 61% of the atoms in the complex. Iterative skeletonization gave better results than either solvent flattening or twofold non-crystallographic symmetry averaging as measured by the reduction in the free R factor [Brünger (1992). Nature (London), 355, 472-474]. Protection of the trypsin density during the course of the refinement greatly improved the performance of both skeletonizing and solvent flattening. In the case of apolipoprotein E, previous attempts using solvent flattening had failed to improve the SIR phases to the point of obtaining an interpretable map. The combination of iterative skeletonization and solvent flattening decreased the phase error with respect to the final refined structure, significantly more than solvent flattening alone. The final maps generated by the skeletonization procedure for both the ecotin-trypsin complex and apolipoprotein E were readily interpretable.
上一篇论文描述了一种用于蛋白质晶体学的相位精修策略,该策略利用了蛋白质由相连的原子线性链组成这一信息。本文将该方法应用于一个分子置换问题,即蛋白酶抑制剂依考汀与胰蛋白酶结合的结构,以及一个单对映体置换问题,即载脂蛋白E的N端结构域的结构。依考汀 - 胰蛋白酶复合物的起始相位基于一个包含复合物中61%原子的部分模型(胰蛋白酶)。通过自由R因子的降低来衡量,迭代骨架化比溶剂平整或二次非晶体学对称性平均给出了更好的结果[布吕格(1992年)。《自然》(伦敦),355,472 - 474]。在精修过程中对胰蛋白酶密度的保护极大地提高了骨架化和溶剂平整的性能。在载脂蛋白E的情况下,之前使用溶剂平整的尝试未能将单对映体置换(SIR)相位改善到获得可解释图谱的程度。迭代骨架化和溶剂平整的结合相对于最终精修结构降低了相位误差,比单独使用溶剂平整显著得多。通过骨架化程序为依考汀 - 胰蛋白酶复合物和载脂蛋白E生成的最终图谱都易于解释。